A novel-generation JAK2 inhibitor: momelotinib

doi:10.3969/j.issn.1672-3384.2024.07.004

PDF(387 KB)

Clinical Medication Journal ›› 2024, Vol. 22 ›› Issue (7) : 18-22. DOI: 10.3969/j.issn.1672-3384.2024.07.004

Comment of New Drug

A novel-generation JAK2 inhibitor: momelotinib

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2024, 22(7): 18-22 https://doi.org/10.3969/j.issn.1672-3384.2024.07.004

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

Funding

RIGHTS & PERMISSIONS

PDF(387 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2023-12-21	2024-07-20
Issue Date
2024-08-08

Please choose a citation manager

Content to export